Table 1.
Summary of human samples.
| Human Sample | Gender (Age) | Reason of Surgery | Long-Term Pharmacotherapy | PCLS Preparation |
|---|---|---|---|---|
| L1 | Female (37) |
CRC 1 | Insulin | No |
| L3 | Male (58) |
CCC 2 | Allopurinol, felodipine, ramipril, indapamide, atorvastatin, citalopram, pregabalin | No |
| L4 | Male (35) |
Adenoma | Mesalazine, omeprazole, escitalopram, budesonide | No |
| L5 | Male (63) |
CRC | Ramipril, atorvastatin, metformin, allopurinol | Yes |
| L6 | Male (69) |
CRC | Hydrochlorothiazide | Yes |
| L7 | Male (69) |
CRC | Nitrendipine, acetylsalicylic acid | Yes |
| L8 | Female (69) |
CRC | Verapamil, trandolapril | No |
| L9 | Male (81) |
CRC | Betaxolol | Yes |
| L10 | Female (66) |
HCC 3 | Pantoprazole | No |
| L11 | Female (57) |
CRC, liver metastases | None | Yes |
| L12 | Female (73) |
CRC | Lerkanidipine, furosemide, perindopril, nadroparin | No |
| L13 | Female (67) |
CCC | Nadroparin | No |
| L14 | Female (45) |
BFNH 4 | None | Yes |
| L15 | Female (69) |
CRC | Nebivolol, simvastatin, digoxin, irbesartan, hydrochlorothiazide, nadroparin | No |
| L16 | Female (59) |
CRC | None | Yes |
| L17 | Male (39) |
CRC | None | No |
| L18 | Male (83) |
HCC | Lacidipine, solifenacin, tamsulosin | No |
| L19 | Female (65) |
CRC | Amlodipine | No |
| L20 | Female (84) |
Abscess | None | No |
| L21 | Male (34) |
Jejunal adenocarcinoma | None | No |
| L22 | Female (84) |
CRC | Telmisartan, nitrendipine, formoterol | No |
| L23 | Male (83) |
CRC | Furosemide, amlodipine, acetylsalicylic acid, telmisartan, salmeterol, fluticasone | No |
| L24 | Male (77) |
HCC | Metoprolol, felodipin, ramipril, metformin, gliclazid, finasteride, warfarin,nadroparin | No |
| L25 | Male (70) |
CRC | Perindopril, betaxolol, metformin, atorvastatin, allopurinol, insulin | No |
| L26 | Male (72) |
CRC | None | No |
| L27 | Male (70) |
CRC | Insulin, atorvastatin | No |
| L28 | Female (26) |
BFNH | None | Yes |
| L29 | Male (59) |
Renal cell carcinoma, liver metastases | None | No |
| L30 | Female (81) |
CRC, liver metastases | Hydrochlorothiazide, betaxolol, acetylsalicylic acid, zolpidem, insulin | Yes |
| L33 | Female (72) |
CCC | Lerkanidipine, irbesartan, hydrochlorothiazide, lansoprazole, levothyroxine, acetylsalicylic acid, fenofibrate, nebivolol | No |
| L34 | Male (62) |
CRC | Ramipril, felodipine, metoprolol, rosuvastatin, acetylsalicylic acid | No |
| L35 | Male (72) |
CRC, liver metastases | Tamsulosin, metoprolol, omeprazole | No |
| L36 | Female (78) |
CCC | Simvastatin, bisoprolol, furosemide, ramipril, enoxaparin, zolpidem | Yes |
| L37 | Male (50) |
Neuroendocrine tumor, liver metastases | Insulin | Yes |
| L38 | Male (59) |
CCC | None | Yes |
1 CRC, colorectal carcinoma; 2 CCC, cholangiocellular carcinoma; 3 HCC, hepatocellular carcinoma; 4 BFNH, benign focal nodular hyperplasia.